Clinical trial · Observational
Multicenter Cross Sectional Study of Primary Intestine Lymphoma
Multicenter Cross Sectional Study of Primary Intestine Lymphoma: Treatment Outcome and Quality of Life
NCT01043302CI-TRIAL-00003719completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to determine whether whether surgical resection followed by chemotherapy is superior to systemic chemotherapy alone in terms of treatment outcome and quality of life (QOL) in patients with primary intestinal lymphoma.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Non-Hodgkin Lymphoma of Intestine | Lymphoma | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- Surgery+chemotherapy
- description
- Primary mass was resected and systemic chemotherapy was performed as an adjuvant treatment
- label
- Chemotherapy
- description
- Only treated with chemotherapy
Primary outcomes (1)
- measure
- Overall survival
- timeFrame
- Study entry
Secondary outcomes (1)
- measure
- Quality of life
- timeFrame
- Study entry
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 15 Years
- Maximum age
- 85 Years
Show eligibility criteria text
Inclusion Criteria: * Primary intestine lymphoma. Definition of primary intestine lymphoma: 1. Dominant site should be small and large intestine with or without regional lymph node involvement 2. Distant lymph node involvement can be allowed if the intestine lesion is the presenting site 3. Contiguous involvement of other organs such as liver, spleen can be allowed Exclusion Criteria: * Intestine involvement as a dissemination process in stage IV nodal lymphoma
References
Publications (1)
- DERIVEDKim SJ, Kang HJ, Kim JS, Oh SY, Choi CW, Lee SI, Won JH, Kim MK, Kwon JH, Mun YC, Kwak JY, Kwon JM, Hwang IG, Kim HJ, Park J, Oh S, Huh J, Ko YH, Suh C, Kim WS. Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: surgical resection followed by chemotherapy versus chemotherapy alone. Blood. 2011 Feb 10;117(6):1958-65. doi: 10.1182/blood-2010-06-288480. Epub 2010 Dec 9. PMID 21148334